Immix Biopharma Inc. (NASDAQ: IMMX) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT IMMIX BIOPHARMA INC.

Immix Biopharma Inc. (NASDAQ: IMMX)
Listen to this Section


$2.00
+0.0300 ( +1.52% ) 49.8K

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Market Data


Open $2.00
Previous Close $1.97
Volume 49.8K
Market Cap $54.19M
Day Range $1.88 - $2.01
52 Week Range $1.26 - $3.80
Shares Outstanding 27.51M
Change % +1.52%
Net Change ▲ 0.0300
Insider Ownership 0.00%
Exchange NASDAQ
Sector Healthcare
Industry Medicinal Chemicals and Botanical Products
IPO Year 2021
Country United States
Under Writer ThinkEquity, more

Insider Ownership Transactions

Total Amount Purchased: -1,774,425.00

Date Type Amount Purchased Purchaser
2024-12-26 Buy 7700.00 Hsu Jason
2024-08-26 Buy 15000.00 Hsu Jason
2024-08-19 Buy 10000.00 Ng Carey
2024-07-31 Buy 3200.00 Hsu Jason
2024-06-21 Sale -33000.00 Chudnovsky Yekaterina
2024-06-21 Sale -33000.00 Hsu Jason
2024-06-21 Sale -33000.00 Ng Carey
2024-06-21 Sale -340000.00 Rachman Ilya M
2024-06-21 Sale -340000.00 Morris Gabriel S
2024-06-21 Sale -33000.00 BUCHAN JANE

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Dec 26, 2024
10-q Quarterly Reports 66 Nov 12, 2024
4 Insider transactions 1 Aug 26, 2024
4 Insider transactions 1 Aug 19, 2024
10-q Quarterly Reports 64 Aug 12, 2024
4 Insider transactions 1 Jul 31, 2024
8-k 8K-related 14 Jul 26, 2024
s-8 Registration statements 8 Jul 22, 2024
8-k 8K-related 14 Jul 22, 2024
4 Insider transactions 1 Jun 21, 2024

Latest News


× Before browsing our site, please accept our cookies policy